INTERNATIONAL PATENT: ALNYLAM PHARMACEUTICALS, INC. FILES APPLICATION FOR "DYSTROPHY MYOTONIC PROTEIN KINASE (DMPK) IRNA COMPOSITIONS AND METHODS OF USE THEREOF"

GENEVA, Dec. 24 -- ALNYLAM PHARMACEUTICALS, INC. (675 West Kendall StreetHenri A. Termeer SquareCambridge, MA 02142) filed a patent application (PCT/US2025/033136) for "DYSTROPHY MYOTONIC PROTEIN KINASE (DMPK) IRNA COMPOSITIONS AND METHODS OF USE THEREOF" on Jun 11, 2025. With publication no. WO/2025/259747, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SCHMIDT, Karyn (675 West Kendall StreetHenri A. Termeer SquareCambridge, MA 02142), SCHLEGEL, Mark, K. (675 West Kendall StreetHenri A. Termeer SquareCambridge, MA 02142...